|
Class 2 Device Recall EPShuttle/Stockert J50/Stockert J70 |
|
Date Initiated by Firm |
July 07, 2011 |
Date Posted |
September 12, 2011 |
Recall Status1 |
Terminated 3 on October 12, 2012 |
Recall Number |
Z-3178-2011 |
Recall Event ID |
59331 |
PMA Number |
P990071 |
Product Classification |
Cardiac ablation percutaneous catheter - Product Code LPB
|
Product |
STOCKERT 70 Radio Frequency Generator, Catalog Number 57001
Indicated for use with a Biosense Webster, Inc. diagnostic/ablation deflectable tip catheter to deliver radio frequency energy during cardiac ablation procedures.
Stockert 70 in foreign countries is also known as: EP-Shuttle/Stockert J50/Stockert J70
With software versions: 1.035/1.035J/1.035J70 to 1.037/1.037J70 |
Code Information |
Software version: 1.035J |
Recalling Firm/ Manufacturer |
Biosense Webster, Inc. 15715 Arrow Hwy Irwindale CA 91706-2006
|
For Additional Information Contact |
909-839-8604
|
Manufacturer Reason for Recall |
Biosense Webster has initiated a voluntary field notification to all customers that have a Stockert 70 Radio Frequency Generator, to communicate undetected software anomalies in the form of software release note in order to amend the labeling and thereby enhance the safety of the product.
|
FDA Determined Cause 2 |
Software design (manufacturing process) |
Action |
The recall communication was initiated on 7/8/11 and 7/11/11 with Biosense Webster forwarding A Customer Notification Letter, Acknowledgement Form and Software Release Note (Attachments 3, 4 and 1) via FedEx to all U.S. customers who purchased the Stockert 70 Radio Frequency Generator.
Two letters and forms were sent to U.S. customers via express mail, addressed to the EP/Cardiology Lab and Risk Management Office, respectively.
The Release Note provides tips for the avoidance of potential events when working with the EP-SH UTTLE, STOCKERT 70, STOCKERT J50 or STOCKERT J70 RF generators with SW versions 1.035 / 1.035J /1.035J70 to 1.037/1.037J70. |
Quantity in Commerce |
3,397 units total (1,217 in U.S.) |
Distribution |
Worldwide Distribution -- Algeria, Argentina, Australia, Austria, Belarus, Belgium, Brazil, Brunei Darussalam, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, England, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Korea, Latvia, Lebanon, Lithuania, Luxembourg, Malaysia, Malta, Mexico, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Norway, Pakistan, Philippines, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tahiti, Taiwan, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database |
PMAs with Product Code = LPB and Original Applicant = BIOSENSE WEBSTER, INC.
|
|
|
|